Metro Healthcare Bhd (XKLS:0329) EBIT: RM9.33 Mil (TTM As of Mar. 2026)


XKLS:0329 Metro Healthcare Bhd XKLS:0329
59 GF Score
Price RM0.22
GF Value RM0.32
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Metro Healthcare Bhd EBIT?

Metro Healthcare Bhd XKLS:0329 59 EBIT is RM9.33 Mil as of Mar. 2026. GuruFocus rates XKLS:0329 with a GF Score™ of 59/100 and a GF Value™ of RM0.32 (Possible Value Trap). The stock has 4 warning signs investors should review.

Metro Healthcare Bhd's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was RM1.32 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was RM9.33 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Metro Healthcare Bhd's annualized ROC % for the quarter that ended in Mar. 2026 was 11.59%. Metro Healthcare Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 13.71%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Metro Healthcare Bhd's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 5.29%.

Metro Healthcare Bhd  (XKLS:0329) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Metro Healthcare Bhd's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=5.28 * ( 1 - 12.5% )/( (37.375 + 42.383)/ 2 )
=4.62/39.879
=11.59 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=92.525 - 1.63 - ( 53.52 - max(0, 5.031 - 59.828+53.52))
=37.375

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=100.792 - 6.326 - ( 52.083 - max(0, 8.237 - 61.971+52.083))
=42.383

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Metro Healthcare Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=5.28/( ( (32.222 + max(3.127, 0)) + (38.136 + max(3.562, 0)) )/ 2 )
=5.28/( ( 35.349 + 41.698 )/ 2 )
=5.28/38.5235
=13.71 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.168 + 2.847 + 3.068) - (1.63 + 0 + 1.326)
=3.127

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4.96 + 3.009 + 1.919) - (6.326 + 0 + 0)
=3.562

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Metro Healthcare Bhd's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=9.331/176.553
=5.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Metro Healthcare Bhd EBIT Related Terms

Metro Healthcare Bhd EBIT Historical Data

* Premium members only.

The historical data trend for Metro Healthcare Bhd's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Metro Healthcare Bhd EBIT Chart

Metro Healthcare Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.98 7.78 9.28 7.87 8.79

Metro Healthcare Bhd Quarterly Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 1.90 3.04 3.08 1.32

XKLS:0329 vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Metro Healthcare Bhd's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Metro Healthcare Bhd EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Metro Healthcare Bhd's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Metro Healthcare Bhd's EV-to-EBIT falls into.


XKLS:0329
59GF Score
Metro Healthcare Bhd XKLS:0329
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Metro Healthcare Bhd EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM9.33 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of RM9.33 Mil mean?
Metro Healthcare Bhd (XKLS:0329) has a EBIT of RM9.33 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Metro Healthcare Bhd.
Is Metro Healthcare Bhd's EBIT too high?
Metro Healthcare Bhd's current EBIT is RM9.33 Mil. Overall, Metro Healthcare Bhd has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Metro Healthcare Bhd's EBIT compare to HCA and THC?
Metro Healthcare Bhd's EBIT of RM9.33 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Metro Healthcare Bhd. Metro Healthcare Bhd's current EBIT is RM9.33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metro Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, Metro Healthcare Bhd (XKLS:0329) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.32, compared to a current price of RM0.22 — trading 32.8% below its estimated fair value. The current EBIT is RM9.33 Mil. Metro Healthcare Bhd's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Metro Healthcare Bhd (XKLS:0329), the current EBIT is RM9.33 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Metro Healthcare Bhd (XKLS:0329) Overvalued in 2026?

Based on GuruFocus' analysis, Metro Healthcare Bhd stock appears to be undervalued. The current stock price of RM0.22 is trading 32.8% below its estimated GF Value™ of RM0.32. GuruFocus considers Metro Healthcare Bhd to be Possible Value Trap.

Key valuation signals for XKLS:0329:

  • EBIT: RM9.33 Mil
  • GF Value™: RM0.32 vs. price of RM0.22 (32.8% below fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the XKLS:0329 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Metro Healthcare Bhd Business Description

Address No. 32, Jalan Pasar, Klang, SGR, MYS, 41400
Metro Healthcare Bhd is engaged in the provision of women healthcare services. The company offers various services such as obstetrics, gynecology impatient services, and diagnostic medical imaging services. It also provides semen analysis, intracytoplasmic sperm injection, blastocyst culture, assisted hatching, frozen embryo transfer, preimplantation genetic screening, and infertility consultation services. The company serves patients in Malaysia. The firm's business segment includes O&G healthcare services, Complementary services, and Hospital services.
59GF Score

Get the complete analysis for XKLS:0329

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.22
Price
RM0.32
GF Value